Here, we show systematic profiling of SLC6A20 expressionin pan-cancer tumor and healthy samples together with correlationwith SARS-CoV-2 infection genes ACE2, TMPRSS2, and TMPRSS4 and immunefiltration in tumor samples. This evidence concerns the gene SLC6A20 and neoplasm.